Cellectis Балансовая стоимость акции
Что обозначает Балансовая стоимость акции в Cellectis?
Балансовая стоимость акции Cellectis является 4.36
Какое определение для Балансовая стоимость акции?
Балансовая стоимость на акцию - это активы компании за вычетом обязательств, разделенные на количество акций в обращении.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Балансовая стоимость акции компаний в Health Care сектор на NASDAQ по сравнению с Cellectis
Что делает Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Компании с балансовая стоимость акции похож на Cellectis
- Morses Club PLC имеет Балансовая стоимость акции из 4.35
- Nokian Renkaat Oyj имеет Балансовая стоимость акции из 4.36
- Tandy Leather Factory имеет Балансовая стоимость акции из 4.36
- Metalla Royalty & Streaming имеет Балансовая стоимость акции из 4.36
- Las Vegas Sands Corp имеет Балансовая стоимость акции из 4.36
- WPP Plc имеет Балансовая стоимость акции из 4.36
- Cellectis имеет Балансовая стоимость акции из 4.36
- Jacques Bogart SA имеет Балансовая стоимость акции из 4.36
- Bowl America имеет Балансовая стоимость акции из 4.36
- Insignia Systems имеет Балансовая стоимость акции из 4.36
- Crown Crafts имеет Балансовая стоимость акции из 4.36
- Co-Diagnostics имеет Балансовая стоимость акции из 4.37
- ASE Technology Co.Ltd имеет Балансовая стоимость акции из 4.37